U.S. market Closed. Opens in 1 day 16 hours 35 minutes

NGNE | Neurogene Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-31
RevenueN/AN/AN/AN/AN/A25.00MN/AN/A
Cost of Revenue3.26M3.20M2.28M1.82M340.00KN/AN/AN/A
Gross Profit-3.26M-3.20M-2.28M-1.82M-340.00K25.00MN/AN/A
Operating Expenses55.58M56.52M50.53M39.73M24.10M48.52M51.12M37.65M
Selling, General & Admin11.19M9.01M8.27M15.39M17.79M15.73M14.85M9.26M
Research & Development44.39M47.51M42.26M24.34M6.32M32.79M36.27M28.38M
Other Operating Expenses-28.00K-7.00KN/AN/AN/AN/AN/AN/A
Operating Income-55.58M-56.52M-50.53M-41.55M-24.44M-23.52M-51.12M-37.65M
Other Expenses / Income19.27M1.33M17.00K8.28M-45.00M-8.06M936.00K643.00K
Before Tax Income-36.32M-55.19M-50.52M-33.28M-69.44M-31.59M-50.18M-37.00M
Income Tax ExpensesN/A-5.00K17.00K-1.00168.14KN/A-1.00-1.00
Net Income-36.32M-55.19M-50.52M-33.28M-69.44M-31.59M-50.18M-37.00M
Interest Expenses12.00K2.00KN/AN/A1.00K4.00K4.00K1.00K
Basic Shares Outstanding12.82M12.82M55.04M51.83M27.03M23.52M23.45M18.89M
Diluted Shares Outstanding12.82M12.82M55.04M51.83M27.03M23.52M23.45M18.89M
EBITDA-52.29M-51.99M-49.59M-31.46M-69.10M-31.58M-50.18M-37.00M
EBITDA Margin0.00%0.00%0.00%0.00%0.00%-126.32%0.00%0.00%
EBIT-36.30M-55.19M-50.50M-33.28M-69.27M-31.58M-50.18M-37.00M
EBIT Margin0.00%0.00%0.00%0.00%0.00%-126.32%0.00%0.00%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙